Published online before print May 26, 2005, doi: 10.1161/01.RES.0000171756.13554.49
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 American Heart Association, Inc.
Molecular Medicine |
Neuropilin-1 Regulates Vascular Endothelial Growth Factor–Mediated Endothelial Permeability
From the Division of Pulmonary and Critical Care Medicine (P.M.B., R.Y., T.M., J.S.K.S., A.D.V.), Johns Hopkins University School of Medicine, Baltimore, Md; University Hospital Maastricht and Cardiovascular Research Institute Maastricht (CARIM) (J.W.), Maastricht, the Netherlands; and the Division of Pulmonary and Critical Care Medicine (C.G.L., J.A.E.), Yale University School of Medicine, New Haven, Conn.
Correspondence to Dr Patrice M. Becker, Johns Hopkins Asthma and Allergy Center, Room 4B74, 5501 Hopkins Bayview Cir, Baltimore, MD 21224. E-mail pbecker1{at}jhmi.edu
Neuropilin-1 (Npn-1) is a cell surface receptor that binds vascular endothelial growth factor (VEGF), a potent mediator of endothelial permeability, chemotaxis, and proliferation. In vitro, Npn-1 can complex with VEGF receptor-2 (VEGFR2) to enhance VEGFR2-mediated endothelial cell chemotaxis and proliferation. To determine the role of Npn-1/VEGFR2 complexes in VEGF-induced endothelial barrier dysfunction, endothelial cells were stably transfected with Npn1 or VEGFR2 alone (PAE/Npn and PAE/KDR, respectively), or VEGFR2 and Npn-1 (PAE/KDR/Npn-1). Permeability, estimated by measurement of transendothelial electrical resistance (TER), of PAE/Npn and PAE/KDR cell lines was not altered by VEGF165. In contrast, TER of PAE/KDR/Npn-1 cells decreased in dose-dependent fashion following VEGF165 (10 to 200 ng/mL). Activation of VEGFR2, and 2 downstream signaling intermediates (p38 and ERK1/2 MAPK) involved in VEGF-mediated permeability, also increased in PAE/KDR/Npn-1. Consistent with these data, inhibition of Npn-1, but not VEGFR2, attenuated VEGF165-mediated permeability of human pulmonary artery endothelial cells (HPAE), and VEGF121 (which cannot ligate Npn-1) did not alter TER of HPAE. Npn-1 inhibition also attenuated both VEGF165-mediated pulmonary vascular leak and activation of VEGFR2, p38, and ERK1/2 MAPK, in inducible lung-specific VEGF transgenic mice. These data support a critical role for Npn-1 in regulating endothelial barrier dysfunction in response to VEGF and suggest that activation of distinct receptor complexes may determine specificity of cellular response to VEGF.
Key Words: vascular endothelial growth factor receptor-2 • transendothelial electrical resistance • chemotaxis • mitogen-activated protein kinase • acute lung injury
This article has been cited by other articles:
 |
|
 |
|
  T. Teesalu, K. N. Sugahara, V. R. Kotamraju, and E. Ruoslahti C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration PNAS, September 22, 2009; 106(38): 16157 - 16162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Le, R. Zielinski, C. He, M. T. Crow, S. Biswal, R. M. Tuder, and P. M. Becker Pulmonary Epithelial Neuropilin-1 Deletion Enhances Development of Cigarette Smoke-induced Emphysema Am. J. Respir. Crit. Care Med., September 1, 2009; 180(5): 396 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. V. Snegovskikh, F. Schatz, F. Arcuri, P. Toti, U. A. Kayisli, W. Murk, Guoyang Luo, C. J. Lockwood, and E. R. Norwitz Intra-Amniotic Infection Upregulates Decidual Cell Vascular Endothelial Growth Factor (VEGF) and Neuropilin-1 and -2 Expression: Implications for Infection-Related Preterm Birth Reproductive Sciences, August 1, 2009; 16(8): 767 - 780. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Fischer, M. Nishio, S. C. Peters, M. Tschernatsch, M. Walberer, S. Weidemann, R. Heidenreich, P. O. Couraud, B. B. Weksler, I. A. Romero, et al. Signaling mechanism of extracellular RNA in endothelial cells FASEB J, July 1, 2009; 23(7): 2100 - 2109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Prahst, M. Heroult, A. A. Lanahan, N. Uziel, O. Kessler, N. Shraga-Heled, M. Simons, G. Neufeld, and H. G. Augustin Neuropilin-1-VEGFR-2 Complexing Requires the PDZ-binding Domain of Neuropilin-1 J. Biol. Chem., September 12, 2008; 283(37): 25110 - 25114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. N. Gavrilovskaya, E. E. Gorbunova, N. A. Mackow, and E. R. Mackow Hantaviruses Direct Endothelial Cell Permeability by Sensitizing Cells to the Vascular Permeability Factor VEGF, while Angiopoietin 1 and Sphingosine 1-Phosphate Inhibit Hantavirus-Directed Permeability J. Virol., June 15, 2008; 82(12): 5797 - 5806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Simons Silky, Sticky Chimeras-Designer VEGFs Display Their Wares Circ. Res., May 25, 2007; 100(10): 1402 - 1404. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zheng, M. Murakami, H. Takahashi, M. Yamauchi, A. Kiba, S. Yamaguchi, N. Yabana, K. Alitalo, and M. Shibuya Chimeric VEGF-ENZ7/PlGF Promotes Angiogenesis Via VEGFR-2 Without Significant Enhancement of Vascular Permeability and Inflammation Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2019 - 2026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bourbie-Vaudaine, N. Blanchard, C. Hivroz, and P.-H. Romeo Dendritic Cells Can Turn CD4+ T Lymphocytes into Vascular Endothelial Growth Factor-Carrying Cells by Intercellular Neuropilin-1 Transfer J. Immunol., August 1, 2006; 177(3): 1460 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Yamagishi, K. Nakamura, T. Matsui, Y. Inagaki, K. Takenaka, Y. Jinnouchi, Y. Yoshida, T. Matsuura, I. Narama, Y. Motomiya, et al. Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species-mediated Vascular Endothelial Growth Factor Expression J. Biol. Chem., July 21, 2006; 281(29): 20213 - 20220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A R L Medford and A B Millar Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax, July 1, 2006; 61(7): 621 - 626. [Abstract] [Full Text] [PDF]
|
|